Organisation paid for research Program year 2025 Source: CMS Open Payments

Avera Breast Center

Neither a doctor nor a teaching hospital

Research payments

$2,273

31 payments

Through program year 2025, Avera Breast Center is reported as receiving $2,273 in research payments, across 31 payments.

By program year

1 row
Year Kind Amount Payments
2025 Research $2,273 31

Breakdown

Who paid Research payments · program year 2025
  1. Boehringer Ingelheim International GmbH $1,446 13 payments
  2. Boehringer Ingelheim Pharma GmbH & Co.KG $827 18 payments
Studies the money was for Research payments · program year 2025
  1. An open label, Phase I dose-finding and expansion study of BI 765179 as monotherapy and in combination with ezabenlimab (BI 754091) in patients with advanced solid cancers, and BI 765179 in combination with pembrolizumab in first-line PD-L1-positive metastatic or incurable, recurrent head and neck squamous cell carcinoma (HNSCC) $2,273 31 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record